Does Beovu help with wet AMD?
Beovu (brolucizumab-dbll) is used to treat wet AMD (also called neovascular age-related macular degeneration) in adults. Two trials (HAWK and Harrier) have reported the benefits with Beovu are similar to those seen with Eylea. Improvements in visual acuity (the ability to see more clearly) started after the first injection of Beovu and were noticeable within 4 weeks, reached their maximum at 48 weeks, and persisted for at least 2 years (the length of the trial).
Beovu is an injection that is administered directly into the eye by a qualified physician. The usual dosage is one injection approximately monthly for the first three doses, then 8 to 12 weekly thereafter.
Wet ADM occurs when abnormal, leaky blood vessels grow under your macula. The macula is the part of your retina at the back of your eye and it is responsible for your central vision. The leaky blood vessels can cause scaring on your macula, leading to blurry vision, wavy lines in your vision, muted colors and blind spots.
References
- Beovu Injection Prescribing Information. Updated 12/2022. Novartis Pharmaceuticals Corporation https://www.drugclasses.com/pro/beovu-injection.html
Read next
Does Medicare cover Beovu?
Yes, Medicare usually covers the costs of Beovu (brolucizumab), a prescription medication used to treat macular degeneration (AMD) and diabetic macular edema (DME). Your specific costs may vary depending on your copays or deductibles, how much your doctor charges, and your type of insurance coverage (private, Medicare, Medicaid). Continue reading
Is Syfovre covered by Medicare?
Medicare Part B covers eye disease treatment Syfovre if you have geographic atrophy (GA) secondary to age-related macular degeneration (AMD). After you meet your Part B deductible, your cost is 20% of the Medicare-approved amount for the drug and services. Check with your Medicare plan for coverage details. Continue reading
What is the difference between Vabysmo and Eylea?
Vabysmo (faricimab) targets vascular endothelial growth factor (VEGF) and angiopoietin-1, whereas Eylea (afibercept) targets VEGF and placental growth factor (P1GF). Both agents are used to treat conditions such as macular degeneration (AMD) and diabetic macular edema and are given by intravitreal injection (into the gel part of the eye). Continue reading
Related medical questions
- What is brolucizumab used for and how does it work?
- How is brolucizumab administered?
- Does Mounjaro cause blurry vision?
- What’s the difference between Eylea, Eylea HD, and Avastin?
- What are anti-VEGF drugs (VEGF inhibitors)?
- How long does Eylea or Eylea HD take to work?
- Does Eylea and Eylea HD raise blood pressure?
- What is the difference between Eylea and Eylea HD?
- When do the Eylea and Eylea HD patents expire?
- How do Izervay and Syfovre compare?
- Does Medicare cover Eylea injections?
- What is the mechanism of action for Vabysmo?
- How effective is Syfovre for macular degeneration?
- Does Eylea have a biosimilar?
- All Eyes on Ibuprofen: What are 10 Things You Need to Know?
- Xiidra vs. Restasis: Which is better for dry eye?
- What drugs cause bags under eyes?
- What is the difference between Cequa and Restasis?
- Can I use expired neomycin and polymyxin b sulfates, dexamethasone ophthalmic?
- Is pink eye (conjunctivitis) a sign of COVID-19?
- Can Restasis damage your eyes?
- Does Tyrvaya reduce inflammation?
- What Vaccines do I need if I'm over 50?
- What are the differences between Iluvien, Retisert and Yutiq intravitreal implants?
- Poison Ivy
- Pink Eye - what you need to know
- What eye condition is Oxervate used to treat?
- What do I need to know about Medications/Vaccinations before I Travel?
Drug information
Related support groups
- Beovu (4 questions, 4 members)
- Brolucizumab (3 questions, 3 members)
- Macular Degeneration (33 questions, 65 members)
- Eye Conditions (85 questions, 217 members)
- Diabetic Macular Edema (12 questions, 5 members)
- Visual Defect/Disturbance (1 questions, 8 members)